Why DSS acquisition won't move the needle in a big way for Astral

Astral Ltd announced acquisition of 60% stake in specialty chemicals firm DSS for a cash consideration of ₹39.11 crore, aimed at backward integration in adhesives, coatings, and construction chemicals. DSS has a modest FY26 revenue base of just ₹3.21 crore (valued at ~20x sales), though management projects ₹500 crore revenue potential over five years at 20-25% Ebitda margins. Analysts remain skeptical, noting the deal is immaterial relative to Astral's ₹6,570 crore FY26 revenue and similar to prior backward integration efforts that have yet to meaningfully contribute.